CD86-Fc-NKG2a (Shattuck Labs)

N/A

Report date: 2025/01/26 19:36:41

Base Information

Drug NameCD86-Fc-NKG2a (Shattuck Labs)
Drug Alias NameCD86 x NKG2a (Shattuck Labs)dual NKG2a checkpoint inhibitor/CD28 costimulator fusion protein (Shattuck Labs)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT-cell-specific surface glycoprotein CD28 agonistsNK cell lectin-like receptor subfamily C member 1 antagonists
TargetsT-cell-specific surface glycoprotein CD28NK cell lectin-like receptor subfamily C member 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShattuck Labs Inc
China Registration ClassN/A

Develop Information

Active CompaniesShattuck Labs Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A